OCUP – ocuphire pharma, inc. (US:NASDAQ)

News

Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting
Ocuphire Pharma to Present at the Aegis Virtual Conference
Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting [Yahoo! Finance]
Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting
First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine Ophthalmic Solution 0.75% (PS) for the Treatment of Decreased Visual Acuity Under Low Light Conditions Following Keratorefractive Surgery [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com